| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193555 | Journal of Thoracic Oncology | 2013 | 5 Pages |
Abstract
Combination chemotherapy with irinotecan and cisplatin was active in patients with LCNEC, but the RR and the overall survival period among the patients with LCNEC seemed to be inferior to those among the patients with SCLC. Small numbers of patients were a major limitation in this study.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Seiji MD, PhD, Hirotsugu MD, Ikuo MD, PhD, Genichiro MD, PhD, Yuichi MD, PhD, Masayuki MD, PhD, Fumihiro MD, Shun-ichi MD, Ryu MD, PhD, Hirohito MD, PhD, Kanji MD, PhD,